Souhaitez-vous accéder aux communiqués récents ?

BROADVIEW, Ill., March 23, 2026 (GLOBE NEWSWIRE) -- Innovative Food Holdings, Inc. (OTCQB: IVFH) (“IVFH” or the “Company”), a national seller of gourmet specialty foods, today announced an updated...

HOUSTON, March 23, 2026 (GLOBE NEWSWIRE) -- Battalion Oil Corporation (NYSE American: BATL, “Battalion” or the “Company”) today announced financial and operating results for the fourth quarter of...

Amsterdam, 23 March 2026 EXOR REPORTS €37.1 BILLION GROSS ASSET VALUE AT END-2025 NAV per share decreased by 8.1% compared to a 5.4% increase in the MSCI World IndexPerformance was driven by...

Phase 1a interim data for ongoing trial of CTIM-76 (CLDN6 x CD3) expected in June 2026 Phase 1a interim data for ongoing trial of CT-95 (MSLN x CD3) expected in September 2026 Cash and cash...

Revenue Growth Driving Group to Record EBITDA •Revenue of $186.5 million with organic revenue growth of 6.2%•Record Adjusted EBITDA of $45.4 million, up 17.7% year over year, achieved at a margin of...

A Mobilicom Tier-1 defense customer won a U.S. Department of War (DoW) Program of Record, indicating a potential production scale orders for the next 5 years  Cash and cash equivalents surge 120% to...

Abivax Announces Full Year 2025 Financial Results and Provides Business Updates ABTECT Phase 3 Data Safety Monitoring Board (DSMB) meeting on March 18, 2026 found no new safety signals; the analysis...

SAN DIEGO, March 23, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated...

– Dosed three cohorts in Phase 1 trial of STRO-004, potential best-in-class Tissue Factor (TF) ADC; on track to report initial clinical data in mid-2026 – – Company announced first wholly owned...

Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update